The Scale of GLP-1 Coverage Across Cignas Business Lines Evanko reiterated how only 15% to 20% of insurance branch Cigna Healthcares clients cover GLP-1s for weight loss
By stopping myostatin from working, IGF-1 LR3 helps cells divide and grow, speeds up fat metabolism, and speeds up muscle repair and muscle mass growth (hypertrophy)
What is unique is that these products are tested on GLP-1 users before they launch to prove that theyre effective
Dysdigestion: Dysdigestion is characterized by discomfort in the upper abdomen, a feeling of fullness, belching, and other symptoms
p53 induces skin aging by depleting Blimp1 + sebaceous gland cells
Zepbound: 2,684% Growth in Its First Full Year on Market Zepbound launched in November 2023 and achieved 2,684% year-over-year revenue growth in its first full year (2024) the fastest launch in obesity drug history